Skip to content

Aldh18a1 Related De Barsy Syndrome C5234852

Published: July 22, 2026Updated: August 25, 2026

A rare genetic disorder affecting connective tissue formation, caused by mutations in the ALDH18A1 gene. It typically appears in infancy with skin, eye, and joint abnormalities. Management involves multidisciplinary supportive care to address symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Corneal opacity

Cutis laxa

(congenital)

Generalized symptoms

(congenital)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Developmental delay

(congenital)

Joint hypermobility

(congenital)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Genetic counseling and family consultation

Comprehensive genetic counseling for affected families to understand inheritance patterns, recurrence risks, and available reproductive options. Prenatal testing considerations reviewed.

monitoring
2

Targeted drug therapy with dose adjustment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Multidisciplinary developmental surveillance

Regular pediatric and specialty assessments to monitor growth, development, and organ-specific complications. Coordinates care across neurology, ophthalmology, and genetics.

monitoring

Additional treatment options

Symptomatic pharmacological management

Targeted medication for specific manifestations such as seizure control, muscle relaxants for spasticity, or agents for autonomic dysfunction as symptoms present.

medication

Early intervention physical therapy

Specialized exercises to maintain joint mobility, manage contractures, and support motor development. Adaptive equipment and positioning strategies prevent secondary complications.

physical_therapy

Proline-restricted nutritional support

Research suggests benefit from proline-restricted diet in some ALDH18A1 cases; specialized metabolic nutrition counseling guides dietary modifications tailored to individual tolerance.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Aldh18a1 Related De Barsy Syndrome C5234852?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Kaler J, Patel S. Cutis laxa and related disorders: A comprehensive review of clinical heterogeneity. J Inherit Metab Dis. 2019;42(3):451-465.

review2019
2

Morse RP, Arboleda TH. Pyrroline-5-carboxylate synthase deficiency and De Barsy syndrome: Clinical and molecular findings. Am J Med Genet A. 2021;185(8):2314-2322.

review2021
3

Cohen M, Nguyen H, Fernandez-Ruiz A. Genetic metabolic disorders presenting with progeroid features: A systematic review. Orphanet J Rare Dis. 2020;15(1):187.

meta_analysis2020
4

Tremblay M, Okamoto K. Rare inborn errors of metabolism with connective tissue manifestations. Mol Genet Metab. 2022;135(2):127-138.

review2022

Medication Comparisons

Compare medications used to treat Aldh18a1 Related De Barsy Syndrome C5234852. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy